BDBM72281 2-N-(2-methylphenyl)-6-(phenylsulfanylmethyl)-1,3,5-triazine-2,4-diamine::MLS000334769::N2-(2-methylphenyl)-6-(phenylsulfanylmethyl)-1,3,5-triazine-2,4-diamine::N2-(2-methylphenyl)-6-[(phenylthio)methyl]-1,3,5-triazine-2,4-diamine::SMR000249527::[4-amino-6-[(phenylthio)methyl]-s-triazin-2-yl]-(o-tolyl)amine::cid_2446017

SMILES Cc1ccccc1Nc1nc(N)nc(CSc2ccccc2)n1

InChI Key InChIKey=DAMLPIVDOPCSSN-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72281   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72281BDBM72281(34-Fluoro-26-(trifluoromethyl)-11,12,21,22,23,24-h...)
Affinity DataIC50: 7.94nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details US Patent